Schizophrenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: A) Patients with schizophrenia according to DSM-5 criteria B) PANSS total score at 60 points or more C) Age : 20-59 years-old D) Out patients E) No hospitalization during the 6 months prior to the trial F) Native Japanese speaker G) Subjects who give full consent in the participation of the study
Exclusion criteria
Exclusion criteria: A) Organic mental disorder B) Alcohol / drug related disorder C) Intellectual Disabilities (DSM-5), Specific Learning Disorder (DSM-5) D) Existing serious suicidal ideation or dangerous behavior
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total Score of PANSS (Positive and Negative Syndrome Scale) | — |
Secondary
| Measure | Time frame |
|---|---|
| Positive Scale, Negative Scale, and General Psychopathology Scale of PANSS ( Positive and Negative Syndrome Scale) Auditory hallucination scale and delusions scale of PSYRATS (Psychotic Symptom Rating Scales) GAF (The Global Assessment of Functioning) SOFAS (Social and Occupational Functioning Assessment Scale) MINI International Neuropsychiatric Interview PSP(Personal and Social Performance Scale) ODSIS (Overall Depression Severity and Impairment Scale) OASIS (Overall Anxiety Severity and Impairment Scale) WHO-QOL26 CBQp (Cognitive Biases Questionnaire for Psychosis) BCSS (Brief Core Schema Scale) Suicidality and self harm on CAARMS Aggression/Dangerous Behavior on CAARMS | — |
Countries
Japan
Contacts
Tohoku University Hospital Department of Psychiatry